ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
63,188.22
0.47%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. KalVista Pharmaceuticals Inc (KALV)

  7. KalVista Pharmaceuticals Inc (KALV) 뉴스

KALV KalVista Pharmaceuticals Inc

12.13
-0.04 (-0.33%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
KalVista Pharmaceuticals Inc KALV 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.04 -0.33% 12.13 05:35:11
개장가 저가 고가 종가 전일 종가
12.24 11.955 12.48 12.13 12.17
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202419:30BWKalVista Pharmaceuticals Reports Inducement Grants Under..
01/05/202419:30BWKalVista Pharmaceuticals Highlights Strategic Plans for..
22/04/202419:30BWKalVista Pharmaceuticals Appoints William C. Fairey to Board..
03/04/202419:30BWKalVista Pharmaceuticals to Present at 23rd Annual Needham..
02/04/202419:30BWKalVista Pharmaceuticals Reports Inducement Grants Under..
18/03/202419:30BWKalVista Pharmaceuticals Presents Real-World Data on Burden..
12/03/202419:30BWKalVista Pharmaceuticals Awarded UK Promising Innovative..
12/03/202405:37EDGAR2Form 8-K - Current report
12/03/202405:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/03/202419:30BWKalVista Pharmaceuticals Reports Third Fiscal Quarter..
09/03/202406:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202420:30BWKalVista Pharmaceuticals to Present HAE Attack Journey Data..
07/03/202420:38EDGAR2Form 8-K - Current report
07/03/202420:30BWKalVista Pharmaceuticals Announces Appointment of Benjamin..
06/03/202420:30BWKalVista Pharmaceuticals to Participate in the Leerink..
04/03/202420:30BWKalVista Pharmaceuticals Reports Inducement Grants Under..
27/02/202420:30BWKalVista Pharmaceuticals Presents Data on Unmet Needs in HAE..
26/02/202420:30BWKalVista Pharmaceuticals Presents Additional Phase 3..
23/02/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202403:22EDGAR2Form SC 13D/A - General statement of acquisition of..
22/02/202411:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202411:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202411:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202411:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202411:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202406:49EDGAR2Form SC 13D/A - General statement of acquisition of..
20/02/202420:30BWKalVista Pharmaceuticals Awarded UK Innovation Passport for..
17/02/202406:32EDGAR2Form 8-K - Current report
17/02/202406:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/02/202406:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202406:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202406:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202406:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202420:30BWKalVista Pharmaceuticals to Present Phase 3 Sebetralstat..
15/02/202420:30BWKalVista Pharmaceuticals Announces Pricing of a $160.1..
15/02/202410:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202407:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/02/202406:18BWKalVista Pharmaceuticals Announces Proposed Public Offering..
15/02/202406:14EDGAR2Form 8-K - Current report
13/02/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202420:55EDGAR2Form 8-K - Current report
13/02/202420:30BWKalVista Pharmaceuticals Reports Phase 3 KONFIDENT Trial..
13/02/202410:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/02/202410:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202407:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/02/202420:30BWKalVista Pharmaceuticals Reports Inducement Grants Under..

최근 히스토리

NASDAQ
KALV
KalVista Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유